483 Boehringer Ingelheim Pharmaceuticals Jul 2018

483 Boehringer Ingelheim Pharmaceuticals Jul 2018

Kent Conforti FDA$119.00 - Available Now

FDA investigators audited the Boehringer Ingelheim Pharmaceuticals - Ridgefield, CT, United States facility and issued inspectional observations (via FDA 483) on 03 Jul 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 03 Jul 2018
  • Location: Ridgefield, United States
  • FEI: 3002295674
Add To Cart